2D Code Reader Offers Unmatched Data Integrity
Micronic has announced the launch of the new Tracxer Code Reader TS201 — an attractively designed product for reading the 2D Data-Matrix codes of single 24-, 48- and 96-well format sample storage tubes.
Incorporating proprietary 'keyboard wedge' functionality the Tracxer Code Reader TS201 is able to automatically scan and decode any 2D Data-Matrix code making this code reader adaptable to almost any application. Using the keyboard wedge high-end decoding engine ensures that the 2D decoding process is highly reliable thereby producing unmatched data integrity. As a plug-and-play device the Tracxer Code Reader TS201 requires no software installations and is very easy-to-use. Designed to increase your productivity — scanning and decoding a tube takes less than one second. An integral light assists easy and unambiguous sample identification.
The compact (26 cm x 13 cm x 17 cm), robust and stable design of the Tracxer Code Reader TS201 combined with affordable pricing makes it an ideal choice for any laboratory / storage facility requiring high integrity scanning of 2D Data-Matrix coded storage tubes.
For further information or to book a demonstration of the Tracxer Code Reader TS201 please contact Micronic Europe BV (Asia, Africa, Europe and Oceania) now on +31 320 277070/email [email protected] or Micronic America LLC (North, Central and South America) on +1 484 480 3372.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance